Cited by 980Nanoparticle-Based Drug DeliveryNanoplatforms for cancer theranosticsExtracellular vesicles in disease

The DOI matches its Crossref record; 160 of the 162 references it cites were found in a registry or an index.

Targeting drugs to tumours using cell membrane-coated nanoparticles

Fang, Ronnie H., Gao, Weiwei, Zhang, Liangfang·2023·Nature Reviews Clinical Oncology

Open this paper in CoChat — free account

Abstract

Traditional cancer therapeutics, such as chemotherapies, are often limited by their non-specific nature, causing harm to non-malignant tissues. Over the past several decades, nanomedicine researchers have sought to address this challenge by developing nanoscale platforms capable of more precisely delivering drug payloads. Cell membrane-coated nanoparticles (CNPs) are an emerging class of nanocarriers that have demonstrated considerable promise for biomedical applications. Consisting of a synthetic nanoparticulate core camouflaged by a layer of naturally derived cell membranes, CNPs are adept at operating within complex biological environments; depending on the type of cell membrane utilized, the resulting biomimetic nanoformulation is conferred with several properties typically associated with the source cell, including improved biocompatibility, immune evasion and tumour targeting. In comparison with traditional functionalization approaches, cell membrane coating provides a streamlined method for creating multifunctional and multi-antigenic nanoparticles. In this Review, we discuss the history and development of CNPs as well as how these platforms have been used for cancer therapy. The application of CNPs for drug delivery, phototherapy and immunotherapy will be described in detail. Translational efforts are currently under way and further research to address key areas of need will ultimately be required to facilitate the successful clinical adoption of CNPs.

Integrity signals

Registry

Crossref · 10.1038/s41571-022-00699-x

Cites

160 of 160 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Shedding light on the cell biology of extracellular vesicles
van Niel, G., D'Angelo, G., & Raposo, G. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.125 · Cited by 8,369
Engineering precision nanoparticles for drug delivery
Mitchell, M. J., Billingsley, M. M., Haley, R. M., Wechsler, M. E., Peppas, N. A., & Langer, R. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0090-8 · Cited by 7,933
Nano based drug delivery systems: recent developments and future prospects
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodríguez-Torres, M. D. P., Acosta‐Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0392-8 · Cited by 7,038
Cancer immunotherapy using checkpoint blockade
Ribas, A., & Wolchok, J. D. (2018) · Science · doi:10.1126/science.aar4060 · Cited by 6,791
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792
Cancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523

Show all 162 references

Research works printed but not linked: 1

McCarthy, E. F. The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas. Iowa Orthop. J. 26, 154–158 (2006).

Sorted by citations

Items 301–400 of 975

Nanotechnology Advances Proteolysis Targeting Chimeras (PROTACs): Transition From Basic Research to Clinical Application
Mu, X., Mu, C., Wang, M., Meng, C., Liu, H., & Lu, H. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s552644 · Cited by 16
Erythrocyte–Cancer Hybrid Membrane-Camouflaged Prussian Blue Nanoparticles with Enhanced Photothermal Therapy in Tumors
Liu, Z., Xie, H., & Wang, T. (2023) · ACS Omega · doi:10.1021/acsomega.3c02370 · Cited by 16
Genetically Engineered Cell Membrane-Coated Nanoparticles with High-Density Customized Membrane Receptor for High-Performance Drug Lead Discovery
Bu, Y., Wu, D., Zhao, Y. H., et al. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c10907 · Cited by 16
Genetically engineered eukaryocyte-bacteria hybrid membrane-camouflaged nanoemulsion for three-pronged synergistic cancer therapy
Zhang, Y., Liao, Y., Bai, F., Xing, S., Wang, M., Dang, Z., Lin, J., & Huang, P. (2023) · Nano Today · doi:10.1016/j.nantod.2023.102076 · Cited by 16
Cancer Cell Membrane-Coated Nanoparticles for Treatment of Oral Tongue Squamous Cell Carcinoma by Combining Photothermal/Photodynamic Therapy and Autophagy Inhibition
Shi, S., Fu, K., Hou, S., Cao, Y., Chang, Y., Hu, X., Yun, X., Zhao, B., Zhang, S., & Yang, J. (2024) · ACS Applied Nano Materials · doi:10.1021/acsanm.4c00421 · Cited by 16
Bioinspired Hf-based metal-organic framework radiosensitizer for nitric oxide-assisted radio-immunotherapy
Li, Q., Niu, M., Liu, L., Zeng, J., Ji, P., Zhou, H., He, J., Chen, W., & Zhang, X. (2024) · Nano Today · doi:10.1016/j.nantod.2024.102447 · Cited by 19
Adipose-Derived Stem-Cell-Membrane-Coated PLGA-PEI Nanoparticles Promote Wound Healing via Efficient Delivery of miR-21
Peng, H., Du, F., Wang, J., Wu, Y., Wei, Q., Chen, A., Duan, Y., Shi, S., Zhang, J., & Yu, S. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16091113 · Cited by 17
Nanoparticle‐Based drug delivery strategies for targeted therapy to hypoxic solid tumors
Wu, Z., Chen, J., Wang, B., Wen, Q., & Fu, S. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.158081 · Cited by 18
Engineered surface design of recognition site-ordered biomimetic sensor for efficient detection of circulating tumor cells
Jia, L., Wang, R., Wang, R., et al. (2024) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2024.116946 · Cited by 15
Bioorthogonal oncolytic-virus nanovesicles combined bio-immunotherapy with CAR-T cells for solid tumors
Huang, G., He, Y., Chen, X., Yin, T., Ma, A.-Q., Zhu, L., Chen, L., Liang, R., Zhang, P., Pan, H., et al. (2024) · Biomaterials Science · doi:10.1039/d4bm01305k · Cited by 16
Refining Single-Atom Catalytic Kinetics for Tumor Homologous-Targeted Catalytic Therapy
Liu, H., Lei, S., Li, H., Wu, J., He, T., Lin, J., & Huang, P. (2025) · Nano-Micro Letters · doi:10.1007/s40820-025-01735-y · Cited by 19
Cell Membranes from Tumor‐Tropic MSCs Screened by a Microfluidic Chip for Drug Nanoparticles Encapsulation and Cancer Targeted Therapy
Song, Y., Shou, X., Sheng, B., Mei, J., Shi, K., Shang, L., & Zhu, X. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202202904 · Cited by 15
Thermal-controlled cellular uptake of “hot” nanoparticles
Chen, H., Dong, X., Ou, L., Ma, C., Yuan, B., & Yang, K. (2023) · Nanoscale · doi:10.1039/d3nr02449k · Cited by 15
Intelligent nanomaterials for cancer therapy: recent progresses and future possibilities
Wang, J., Zhao, Y., & Nie, G. (2023) · Medical Review · doi:10.1515/mr-2023-0028 · Cited by 15
A PEG-assisted membrane coating to prepare biomimetic mesoporous silicon for PET/CT imaging of triple-negative breast cancer
Wen, H., Martínez, M. G., Happonen, E., Qian, J., Gómez‐Vallejo, V., Mendazona, H. J., Jokivarsi, K. T., Scaravilli, M., Latonen, L., Llop, J., et al. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123764 · Cited by 17
Mechanistic insights into zinc oxide nanoparticles induced embryotoxicity via H3K9me3 modulation
Liu, X., Li, J., Zhu, L., Huang, J., Zhang, Q., Wang, J., Xie, J., Dong, Q., Zou, Z., Huang, G., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122679 · Cited by 15
Cell membrane-coated mRNA nanoparticles for enhanced delivery to dendritic cells and immunotherapy
Li, Q., Byun, J., Kim, D., Wu, Y., Lee, J., & Oh, Y. (2024) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2024.100968 · Cited by 15
IL-11-Engineered Macrophage Membrane-Coated Reactive Oxygen Species-Responsive Nanoparticles for Targeted Delivery of Doxorubicin to Osteosarcoma
Jiang, H., Luo, Y., Li, B., Wu, C., Wang, D., Xin, Y., Xu, W., & Xiao, J. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c11516 · Cited by 16
Exosome-based cell therapy for diabetic foot ulcers: Present and prospect
Yang, Z., Yang, M.-L., Rui, S., Hao, W., Wu, X., Guo, L. Y., Armstrong, D. G., Yang, C., & Deng, W. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39251 · Cited by 16
Polymers for mRNA Delivery
Wang, H., & Cheng, Y. (2025) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.70002 · Cited by 16
Viral and nonviral nanocarriers for in vivo CRISPR-based gene editing
Guo, Z., Zhu, A. T., Fang, R. H., & Zhang, L. (2024) · Nano Research · doi:10.1007/s12274-024-6748-5 · Cited by 18
Self-citation
Treatment of atherosclerosis by biomimetic responsive-targeting hybrid nanoparticles enabled by genetically engineering cell membranes and nucleic acid nanostructures for atorvastatin delivery
Chen, T., Lv, W., Yang, M., et al. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.162130 · Cited by 14
Specific macrophage RhoA targeting CRISPR-Cas9 for mitigating osteoclastogenesis-induced joint damage in inflammatory arthritis
Chen, J., Tan, J., Wang, N., Li, H., Cheng, W., Li, J., Wang, B., Sedgwick, A. C., Chen, Z., Chen, G., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102046 · Cited by 14
Inhalable biomimetic polyunsaturated fatty acid-based nanoreactors for peroxynitrite-augmented ferroptosis potentiate radiotherapy in lung cancer
Chen, Y.-T., Huang, X., Hu, R., Lu, E., Luo, K., Yan, X., Zhang, Z., Ma, Y., Zhang, M., & Sha, X. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03409-8 · Cited by 17
A Review of Silica-Based Nanoplatforms for Anticancer Cargo Delivery
Mosseri, A., Sanchez-Uriel, L., García-Peiro, J. I., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125850 · Cited by 14
Biomimetic targeted self-adaptive nanodrug for inflammation optimization and AT2 cell modulation in precise ARDS therapy
Chen, C., He, D., Li, X., Ou, Z., Wang, H., Shou, Z., Li, W., Mao, Z., Qi, X., & Deng, J. (2025) · Science Advances · doi:10.1126/sciadv.adw5133 · Cited by 17
Efficient copper ion transport triggers in situ photothermia and cuproptosis for boosting colon cancer immunotherapy
Zhang, Y., Sun, W., Meng, X., Yang, X., Su, L., Huang, P., Zhu, D., Dong, X., Mei, L., & Lv, F. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123759 · Cited by 17
Mimic, target, and adapt: Cell membrane‐coated nanoplatforms for precision and immune‐guided cancer treatment
Alam, A. K. M. M., Cai, X., Khan, M. I. U., Musioł, R., & Shubhra, Q. T. H. (2026) · BMEMat · doi:10.1002/bmm2.70074 · Cited by 14
Targeted co-delivery of FOXM1 aptamer and DOX by nucleolin aptamer-functionalized pH-responsive biocompatible nanodelivery system to enhance therapeutic efficacy against breast cancer: in vitro and in vivo
Masoudi, M., Taghdisi, S. M., Hashemitabar, G., & Abnous, K. (2023) · Drug Delivery and Translational Research · doi:10.1007/s13346-023-01495-5 · Cited by 14
MRI-guided cell membrane-camouflaged bimetallic coordination nanoplatform for combined tumor phototherapy
Zhou, M., Wang, Y., Xia, Y., et al. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101019 · Cited by 14
New Transferrin Receptor-Targeted Peptide–Doxorubicin Conjugates: Synthesis and In Vitro Antitumor Activity
Yu, J., Mao, X., Yang, X., et al. (2024) · Molecules · doi:10.3390/molecules29081758 · Cited by 14
Advanced Nano-Drug Delivery Systems in the Treatment of Ischemic Stroke
Zhang, J., Chen, Z., & Chen, Q. (2024) · Molecules · doi:10.3390/molecules29081848 · Cited by 14
Engineering macrophages and their derivatives: A new hope for antitumor therapy
Fang, W., Liu, H., Wang, Y., Li, Y., & Han, S. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116925 · Cited by 17
Dual‐Responsive Nanoreactor Initiates In Situ Generation of Copper Complex for Paraptosis‐Mediated Tumor Chemo‐Immunotherapy
Niu, M., Li, Q., Huang, Q., Liu, L., Qin, Y., Wu, C., Cheng, S., & Zhang, X. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202404822 · Cited by 15
Nanoparticles-Delivered Circular RNA Strategy as a Novel Antitumor Approach
Racca, L., Liuzzi, E., Comparato, S., Giordano, G., & Pignochino, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168934 · Cited by 15
Genetically engineered CD276-anchoring biomimetic nanovesicles target senescent escaped tumor cells to overcome chemoresistant and immunosuppressive breast cancer
Liu, B., Lv, M., Duan, Y., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122796 · Cited by 14
Bioengineering nanomaterials for tumor therapy and anti-metastasis
Cheng, J., Pan, Y., Zou, J., Zhang, M., Zhu, Y., Liu, Y., & Chen, X. S. (2024) · Progress in Materials Science · doi:10.1016/j.pmatsci.2024.101375 · Cited by 15
Intranasal delivery of macrophage cell membrane cloaked biomimetic drug-nanoparticle system attenuates acute lung injury
Zhao, Y., Shen, X., Fan, Y., et al. (2024) · Journal of Tissue Engineering · doi:10.1177/20417314241287487 · Cited by 14
Engineered macrophage nanoparticles enhance microwave ablation efficacy in osteosarcoma via targeting the CD47-SIRPα Axis: A novel Biomimetic immunotherapeutic approach
Ji, X., Qian, X., Luo, G., Yang, W., Huang, W., Lei, Z., Zhou, J., Zhong, G., Zhou, J., Liu, N., et al. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.01.012 · Cited by 17
The improving strategies and applications of nanotechnology-based drugs in hepatocellular carcinoma treatment
Ren, X., Su, D., Shi, D., & Xiang, X. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1272850 · Cited by 15
Strategies for engineering biomimetic materials for tumor therapy
Ma, Z., Zhang, K., & Zhao, Y. (2025) · Matter · doi:10.1016/j.matt.2024.10.017 · Cited by 13
Recent advances in nanomaterial-based brain-targeted delivery systems for glioblastoma therapy
Qu, M., Wang, Q., Wang, X., Tang, J., Dong, X., Zhao, C., & Guan, Q. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2503694 · Cited by 15
Advances in constructing biocompatible nanocarriers
Duan, X., Chu, X., Du, Y., & Tang, Y. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01893-x · Cited by 13
Nasal nanotherapeutics for central nervous system disorders: Bridging the translational gap in central nervous system drug delivery
Zhang, Y.-B., Liu, M., Wang, Y., Hu, D., Wu, S., Zhao, B., Zhou, B., & Yang, L. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177958 · Cited by 14
Biomimetic Platelet Membrane-Based Polyphenol–CeO2 Nanozyme Complex: A Broad-Spectrum Antioxidative System for Comprehensive Atherosclerosis Treatment
Chen, Y., Tang, Q., Zhu, Q., et al. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c06637 · Cited by 13
Self-citation
Advanced Drug Delivery Strategies for Overcoming Biological Barriers: Tumor Microenvironment and Blood–Brain Barrier
Lei, Y., Xiao, T., Hu, X., & Lin, H. (2026) · Drugs in R&D · doi:10.1007/s40268-026-00538-9 · Cited by 14
Immunosuppressive dead cell as lung-targeting vehicle and cytokine absorption material for cytokine storm attenuation of pneumonia
Ci, T., Xiong, Y., Zhang, J., Zang, J., & Feng, N. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100684 · Cited by 13
Biocompatible Ferrofluid‐Based Millirobot for Tumor Photothermal Therapy in Near‐Infrared‐II Window
Ji, Y., Bai, X., Sun, H., Wang, L., Gan, C., Jia, L., Xu, J., Zhang, W., Wang, L., Xu, Y., et al. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202302395 · Cited by 13
Targeted Radium Alpha Therapy in the Era of Nanomedicine: In Vivo Results
Trencsényi, G., Csikos, C., & Képes, Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25010664 · Cited by 13
Biomimetic, folic acid-modified mesoporous silica nanoparticles with “stealth” and “homing” capabilities for tumor therapy
Hu, X., Xiong, W., Liu, X., Wang, J., Wang, S., Chen, Q., Gao, K., Li, C., & Li, Y. (2024) · Materials & Design · doi:10.1016/j.matdes.2024.112899 · Cited by 14
Autologous material-inspired drug delivery systems
Feng, H., Cheng, I., Liu, F., Gu, Z., & Li, H. (2024) · Science China Materials · doi:10.1007/s40843-024-2935-y · Cited by 13
Designing macrophage membrane-engineered ruthenium/selenium nanoparticles to block bone metastasis of breast cancer
Yang, M., Tang, Z., Li, X., Yu, Y., He, L., & Chen, T. (2024) · Nano Research · doi:10.1007/s12274-024-6760-9 · Cited by 13
A tumor targeted nano micelle carrying astragaloside IV for combination treatment of bladder cancer
Kong, C., Sun, J.-R., Hu, X., Li, G., & Wu, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-66010-3 · Cited by 13
Urease-powered micro/nanomotors: Current progress and challenges
Li, W., Yu, Z., & Jia, J. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.101095 · Cited by 13
Rational Engineering of Cytosolic Delivery Systems for Protein Therapeutics
Lv, J., Liu, X., Yin, L., & Cheng, Y. (2024) · Accounts of Materials Research · doi:10.1021/accountsmr.4c00149 · Cited by 13
Recent Advances in Nanodrug Delivery Systems Production, Efficacy, Safety, and Toxicity
Lopalco, A., Iacobazzi, R. M., Lopedota, A., & Denora, N. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-4003-6_15 · Cited by 16
Engineered Biomimetic Nanovesicles Synergistically Remodel Folate-Nucleotide and γ-Aminobutyric Acid Metabolism to Overcome Sunitinib-Resistant Renal Cell Carcinoma
Lv, M., Liu, B., Duan, Y., Lin, J., Li, D., Li, Y., Yu, J., Liao, J., Zhang, J., & Duan, Y. (2024) · ACS Nano · doi:10.1021/acsnano.4c08055 · Cited by 15
Integrated cell membrane encapsulated PQDs-TK quantum dot nanoclusters with ROS-responsive triggering for efficient and visualized DNA delivery
Wang, T., Sun, Y., Zeng, D., et al. (2024) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2024.12.159 · Cited by 13
Biomimetic Co‐delivery of Lenvatinib and FePt Nanoparticles for Enhanced Ferroptosis/Apoptosis Treatment of Hepatocellular Carcinoma
Xuan, F., Zhao, X., Pang, W., Li, Z., Yin, X., Xie, W., Zeng, X., Nie, L., Yang, J., Li, S., et al. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202401747 · Cited by 14
Cell membrane derived biomimetic nanomedicine for precision delivery of traditional Chinese medicine in cancer therapy
Xiao, H., Raza, F., Li, K., Song, J., Zafar, H., Yang, S., Su, J., & Qiu, M. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113829 · Cited by 13
Shedding Light on the Cellular Uptake Mechanisms of Bioactive Glass Nanoparticles as Controlled Intracellular Delivery Platforms: A Review of the Recent Literature
Damian‐Buda, A., & Boccaccini, A. R. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202502754 · Cited by 13
Potential of the nanoplatform and PROTAC interface to achieve targeted protein degradation through the Ubiquitin–Proteasome system
Xie, H., & Zhang, C. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116168 · Cited by 14
Near-Infrared Organic Small-Molecule Fluorophores for Biological System and Organ-Level Imaging of Diseases: Recent Advances
Murugan, P., Yang, F., Yu, C., & Liu, S. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.5c06334 · Cited by 15
Priming the Liver Endocytic Pathway to Accelerate Hepatobiliary Clearance of Nanoparticles
Ren, Y., Mei, F., Lu, H., Liang, Y., Zheng, R., Wang, Z., Liang, F., Du, B., & Jiang, X. (2026) · ACS Nano · doi:10.1021/acsnano.5c20532 · Cited by 12
Engineering stem cell-based nanotherapeutics to overcome myocardial ischemia-reperfusion injury
Li, X., Li, Z., Liu, J., Zang, H., Guo, S., Yang, Y., Tan, X., Liao, J., & Wang, C. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124121 · Cited by 13
Single Low-Dose Nanovaccine for Long-Term Protection against Anthrax Toxins
Holay, M., Krishnan, N., Zhou, J., et al. (2022) · Nano Letters · doi:10.1021/acs.nanolett.2c03881 · Cited by 12
Self-citation
Cancer cell membrane camouflaging mesoporous nanoplatform interfering with cellular redox homeostasis to amplify photodynamic therapy on oral carcinoma
Wu, Q., Ning, H., Wang, H., et al. (2023) · Journal of drug targeting · doi:10.1080/1061186x.2023.2198172 · Cited by 12
Potential targets and applications of nanodrug targeting myeloid cells in osteosarcoma for the enhancement of immunotherapy
Zhu, J., Fan, J., Xia, Y., Wang, H., Li, Y., Feng, Z., & Fu, C. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1271321 · Cited by 13
Therapeutic regulation of epigenetics in cancer treatment through drug delivery systems
Su, B., Li, S., Geng, S., Brambilla, D., Sun, R., Sun, T., & Jiang, C. (2024) · Nano Today · doi:10.1016/j.nantod.2024.102251 · Cited by 12
A minimalist cancer cell membrane-shielded biomimetic nanoparticle for nasopharyngeal carcinoma active-targeting therapy
Sun, S., Han, R., Sun, Y., et al. (2024) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2024.113909 · Cited by 12
Macrophage‐Derived Nanosponges Adsorb Cytokines and Modulate Macrophage Polarization for Renal Cell Carcinoma Immunotherapy
Jiang, Y., Nie, D., Hu, Z., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202400303 · Cited by 12
Novel approaches for bacterial toxin neutralization; current advances and future perspectives
Doroudian, M., Ardalan, M. A., Beheshti, M., et al. (2024) · QJM · doi:10.1093/qjmed/hcae113 · Cited by 12
Nanotechnology as a new strategy for the diagnosis and treatment of gliomas
Lei, J., Huang, Y., Zhao, Y., et al. (2024) · Journal of Cancer · doi:10.7150/jca.96859 · Cited by 12
Recent progress in diagnostic imaging and therapeutics of osteosarcoma based on multifunctional nanoparticles
Yan, X., Lin, D., Yan, D., Wang, D., & Su, H. (2024) · Science China Chemistry · doi:10.1007/s11426-024-2101-1 · Cited by 13
Interpretable Causal System Optimization Framework for the Advancement of Biological Effect Prediction and Redesign of Nanoparticles
Xu, D., Hu, X., Yu, F., Deng, P., & Jia, Y. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c07700 · Cited by 12
Cell membrane camouflaged Cu-doped mesoporous polydopamine for combined CT/PTT/CDT synergistic treatment of breast cancer
Meng, D., Yang, S., Ju, L., Wang, J., Yang, Y., Zhang, L., & Cui, L. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117539 · Cited by 12
Self-citation
Industrial-level production of ultrastable selenium nanoparticles using a confined coordination synthetic strategy
He, L., Zhang, Z., Tang, Z., et al. (2024) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2024.102303 · Cited by 12
Lipid Nanovesicles in Cancer Treatment: Improving Targeting and Stability of Antisense Oligonucleotides
Ding, H.-Y., Zhou, H., Jiang, Y., Chen, S.-S., Wu, X., Li, Y., Luo, J. P., Zhang, P.-F., & Ding, Y. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s507402 · Cited by 12
A tumor microenvironment-responsive Zr-MOF nanosystem for co-delivering siHIF-1α and triptolide enhances photodynamic therapy in esophageal cancer by amplifying ROS generation and reversing hypoxia
Liu, W., Sun, C., Dai, Y., Wang, H., Ashrafizadeh, M., Conde, J., Yang, L., & He, W. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102183 · Cited by 12
Bacterial Membrane Mimetics: From Biosensing to Disease Prevention and Treatment
Arya, S. S., Morsy, N., Islayem, D. K., Alkhatib, S., Pitsalidis, C., & Pappa, A. (2023) · Biosensors · doi:10.3390/bios13020189 · Cited by 15
Bioengineered nanogenerator with sustainable reactive oxygen species storm for self-reinforcing sono-chemodynamic oncotherapy
Shi, D., Wu, F., Huang, L., et al. (2023) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2023.05.081 · Cited by 12
Multistage Self-Assembled Nanomaterials for Cancer Immunotherapy
Guo, L., Yang, J., Wang, H., & Yi, Y. (2023) · Molecules · doi:10.3390/molecules28237750 · Cited by 12
Advancements in dual-targeting nanoparticle strategies for enhanced atherosclerosis therapy: Overcoming limitations of single-targeting approaches
Yang, C., Mo, L., Zhang, G., Dai, Y., Li, B., Tan, Z., Guo, Y., Lu, S., Hong, Y., He, H., et al. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.09.023 · Cited by 13
Trained immunity in atherosclerosis: plasticity, metabolic-vascular axis, and AI-driven precision remodeling
Zhao, B., Wan, J., Zhou, H., Yang, J., & Wan, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1669796 · Cited by 14
Biomimetic cell membrane-mediated nanodelivery platform based on natural products: Emerging strategies for cancer combination therapy
Jiang, Y., Hu, Z., Wei, Y., Su, Y., Yang, Y., Aikedai, A., Liao, W., Wei, Y., Zeng, X., Qian, K., et al. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123908 · Cited by 14
Therapeutic applications of cell membrane-coated nanoparticles in oral diseases: Opportunities, challenges, and future perspectives
Kwa, S. M., Bai, Z., & Toh, W. S. (2026) · Dental Research · doi:10.1016/j.dtrs.2025.100007 · Cited by 11
Self-delivery of a metal-coordinated anti-angiogenic nanodrug with GSH depleting ability for synergistic chemo-phototherapy
Zhu, F., Huang, C., Lin, Y., Li, Y., Tu, R., & Lu, W. (2023) · Biomaterials Science · doi:10.1039/d3bm00994g · Cited by 12
Acid-etched layered double hydroxides armed with dual “Doorkeepers” for Immunomodulatory-NIR III photodynamic therapy of hepatocellular carcinoma
Lu, Y., Zhou, Q.-M., Yang, X., Zhou, J.-P., Wang, X.-J., Yu, J., Zhang, J.-G., Du, Y., & Yu, R. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.148610 · Cited by 11
Current status and future application of electrically controlled micro/nanorobots in biomedicine
Pu, R., Yang, X., Mu, H., Xu, Z., & He, J. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1353660 · Cited by 13
Engineering biomimetic nanosystem targeting multiple tumor radioresistance hallmarks for enhanced radiotherapy
Wang, S., Cao, H., Zhao, C., Wang, Q., Wang, D., Liu, J., Yang, L., & Liu, J. (2024) · Science China Life Sciences · doi:10.1007/s11427-023-2528-5 · Cited by 11
Cell-membrane engineering strategies for clinic-guided design of nanomedicine
Huang, D., Wang, X., Wang, W., Li, J., Zhang, X., & Xia, B. (2024) · Biomaterials Science · doi:10.1039/d3bm02114a · Cited by 11
Cell Membrane Hybrid Lipid Nanovesicles Enhance Innate Immunity for Synergistic Immunotherapy by Promoting Immunogenic Cell Death and cGAS Activation
Qian, R., Guo, Y., Wang, R., Wang, S., Gao, X., Zhu, Z., Wang, K., Zhu, K., Jia, B., Chen, Y., et al. (2024) · Biomaterials Research · doi:10.34133/bmr.0038 · Cited by 11
Hybrid cell membranes camouflaged copper-loaded nano-prodrug for tumor angiogenesis inhibition and cell cuproptosis
Qin, X., Zhu, L., An, X., et al. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.152323 · Cited by 11
Reactive oxygen species-responsive nanotherapy for the prevention and treatment of cerebral ischemia–reperfusion injury
Kong, J., Chu, R., Wen, J., Yu, H., Liu, J., Sun, Y., Mao, M., Ge, X., Jin, Z., Huang, W., et al. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.153023 · Cited by 11
Nanomaterial-Based Strategies for Attenuating T-Cell-Mediated Immunodepression in Stroke Patients: Advancing Research Perspectives
Wang, Y., Liu, C., Ren, Y., Song, J., Fan, K., Gao, L., Ji, X., Chen, X. S., & Zhao, H. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s456632 · Cited by 11
Bovine serum albumin-bound homologous targeted nanoparticles for breast cancer combinatorial therapy
Chen, C., Xie, B., Sun, S., Guo, S., Yang, Z., Yang, L., Zhang, Y., Li, S., Sun, W., Wang, Z., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.136090 · Cited by 11
Manipulating Silver Nanoparticles with Biomolecular Corona Secreted from Vertebrates to Improve the Loading Capacity and Biocompatibility
Yang, Y., Zhu, L. Y., Chen, X., Sun, Y., Yang, R., Zhang, N., & Zhang, Y. (2024) · ACS Nano · doi:10.1021/acsnano.4c08122 · Cited by 9
Biomimetic astrocyte cell membrane-fused nanovesicles for protecting neurovascular units in hypoxic ischemic encephalopathy
Liu, Z., Xia, Q., Wang, C., Xu, J., Tian, K., Wang, Z., Li, L., Li, Y., Shang, H., Liu, Q., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-03053-8 · Cited by 11
Functionalized biomimetic nanoparticles loaded with salvianolic acid B for synergistic targeted triple-negative breast cancer treatment
Cheng, N., Zhou, Q., Jia, Z., Yang, M., Zhang, S., Wang, L., & Chen, Y. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101441 · Cited by 11
Cryoshocked Adipocytes Mediated Dual‐Modal Strategy Combining Photodynamic Therapy and Triptolide Palmitate for Pulmonary Metastatic Melanoma Treatment
Li, A., Fu, Q., Zeng, Y., et al. (2025) · Advanced Science · doi:10.1002/advs.202414307 · Cited by 11

Authors: Fang, R. H., Gao, W., & Zhang, L.
Affiliations: University of California San Diego (US)
Corresponding author: Zhang, Liangfang
ORCID: Fang, Ronnie H.
Gao, Weiwei
Zhang, Liangfang
Venue: Nature Reviews Clinical Oncology
Publisher: Springer Science and Business Media LLC
Published: 2022-10-28
Volume: 20
Issue: 1
Pages: 33-48
ISSN: 1759-4774 (ISSN-L)
1759-4782
DOI: 10.1038/s41571-022-00699-x
OpenAlex: W4307475977
Semantic Scholar: aad18fe7d6405872bceb0dd4451cf81880d894d6
Cited by: 980
References: 162
Citations by year: 2026: 249 · 2025: 320 · 2024: 281 · 2023: 129 · 2022: 1
FWCI: 12.57
Type: journal article
Language: en
Open access: closed
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature Reviews Clinical Oncology (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (R01CA200574)
Topics: Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
Keywords: cell membrane-coated nanoparticles, anticancer drug delivery, tumor targeting, biomimetic nanocarriers, immune evasion, phototherapy, cancer immunotherapy, nanoparticle biocompatibility
MeSH terms: Cell Membrane, Pharmaceutical Preparations, Humans, Neoplasms, Drug Delivery Systems, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Targeting drugs to tumours using cell membrane-coated nanoparticles

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks